Light
Dark
System
Log In
Loading...
Compare / EASA/
Incorporated Amendments
/
Compare & Highlight Differences
AMC1 MED.B.085 Dermatology
Available versions for ERULES-1963177438-11194
ED Decision 2019/002/R
found in: Aircrew (1178/2011) Part-FCL Part-MED Part-CC Part-ARA Part-ORA Part-DTO (Dec 2024)
From
Aircrew (1178/2011... (Nov 2025)
Aircrew (1178/2011... (Dec 2024)
Aircrew (1178/2011... (Aug 2023)
From section
To
Aircrew (1178/2011... (Nov 2025)
Aircrew (1178/2011... (Dec 2024)
Aircrew (1178/2011... (Aug 2023)
To section
No visible text changes
0 removals
0 additions
View
Rich
Plain
Sync scrolling
Share
From
Show details
Hide details
To
Show details
Hide details
Version
Show side by side
AMC1 MED.B.085 Dermatology ED Decision 2019/002/R (a) If doubt exists about the fitness of applicants with eczema (exogenous and endogenous), severe psoriasis, bacterial infections, drug induced or bullous eruptions or urticaria, the AME should refer the case to the medical assessor of the licensing authority. (b)Systemic effects of radiant or pharmacological treatment for a dermatological condition should be reviewed before a fit assessment may be considered. (c)In cases where a dermatological condition is associated with a systemic illness, full consideration should be given to the underlying illness before a fit assessment may be considered.
AMC1 MED.B.085 Dermatology ED Decision 2019/002/R (a) If doubt exists about the fitness of applicants with eczema (exogenous and endogenous), severe psoriasis, bacterial infections, drug induced or bullous eruptions or urticaria, the AME should refer the case to the medical assessor of the licensing authority. (b)Systemic effects of radiant or pharmacological treatment for a dermatological condition should be reviewed before a fit assessment may be considered. (c)In cases where a dermatological condition is associated with a systemic illness, full consideration should be given to the underlying illness before a fit assessment may be considered.
##### AMC1 MED.B.085 Dermatology *ED Decision 2019/002/R* (a) If doubt exists about the fitness of applicants with eczema (exogenous and endogenous), severe psoriasis, bacterial infections, drug induced or bullous eruptions or urticaria, the AME should refer the case to the medical assessor of the licensing authority. (b)Systemic effects of radiant or pharmacological treatment for a dermatological condition should be reviewed before a fit assessment may be considered. (c)In cases where a dermatological condition is associated with a systemic illness, full consideration should be given to the underlying illness before a fit assessment may be considered.